This study compared the measurements of total cholesterol levels by means of a Reflotron dry-chemistry system and a standard laboratory method with the Hitachi 705 analyser. Simultaneous blood samples were collected by finger-prick and by venepuncture from 80 volunteers. The ranges of total cholesterol levels were 3.38-8.45 mmol/L (Reflotron) and 3.59-8.83 mmol/L (Hitachi). The mean (+/- standard deviation [SD]) difference between the two methods was 0.22 +/- 0.30 mmol/L. All the subjects provided a second finger-prick sample of blood on the next day to assess the reproducibility of the Reflotron system. The mean (+/- SD) cholesterol levels that were obtained by the Reflotron method on Day 1 and Day 2 were 5.38 +/- 1.17 mmol/L and 5.30 +/- 1.14 mmol/L, respectively. These results did not differ significantly (mean difference, 0.079 mmol/L; standard error, 0.045 mmol/L). Provided that the operator is trained appropriately, the Reflotron system gives rapid, accurate and reproducible results.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cholesterol levels
16
total cholesterol
12
reflotron dry-chemistry
8
dry-chemistry system
8
levels reflotron
8
reflotron system
8
mmol/l
7
reflotron
5
+/-
5
accurately reflotron
4

Similar Publications

This study aims to determine and compare the reference values of the haematological and biochemical blood parameters of two fish species collected from the Gökova Bay (Muğla, South-Western of Türkiye): the non-native and invasive Randall's threadfin bream, and the native Common pandora, . Both species inhabit the same environment and compete for resources. Blood samples were collected from a total of 100 fish samples (50 and 50 ) which were caught from a depth of 30 to 60 meters between February 2023 and July 2024.

View Article and Find Full Text PDF

Zhilong Huoxue Tongyu capsule protects against atherosclerosis by suppressing EndMT via modulating Hippo/YAP signaling pathway.

J Tradit Complement Med

November 2024

National Traditional Chinese Medicine Clinical Research Base and Drug Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, China.

Background And Aim: Zhilong Huoxue Tongyu Capsule (ZL capsule) has been demonstrated to be an effective and widely-used traditional Chinese medicine (TCM) formula for the treatment of various diseases, especially for atherosclerosis (AS) related cardiovascular and cerebrovascular diseases. Reversal of endothelial-mesenchymal transition (EndMT) plays a crucial role in the cure of AS. But the curative impact of ZL capsule on EndMT remains obscure during the development of AS.

View Article and Find Full Text PDF

Objective: This study investigates the protective effects of lactic acid, a metabolite of , on non-alcoholic fatty liver disease (NAFLD) induced by a high-sugar, high-fat diet (HFD) in mice, in the context of the gut-liver axis.

Methods: A NAFLD mouse model was established using a HFD, and different intervention groups were set up to study the protective effects of and its metabolite lactic acid. The groups included a control group, NAFLD group, treatment group, Glyceraldehyde-3-P (G-3P) co-treatment group, and NOD-like receptor family pyrin domain containing 3 (NLRP3) overexpression group.

View Article and Find Full Text PDF

Objectives: To investigate the natural product sulforaphane (SFN) in protection of membranous nephropathy (MN) by inhibiting oxidative stress-associated podocyte pyroptosis.

Materials And Methods: A passive Heymann nephritis (PHN) model was established and treated with SFN. Clinical manifestations were examined by testing 24-hr urine protein, albumin, total cholesterol, triglyceride, high-density and low-density lipoprotein levels.

View Article and Find Full Text PDF

Lipid-Lowering Drugs and Pulmonary Vascular Disease: A Mendelian Randomization Study.

Pulm Circ

January 2025

Center of Gerontology and Geriatrics National Clinical Research Center for Geriatrics,West China Hospital, Sichuan University Chengdu China.

The therapeutic value of lipid-lowering drugs in pulmonary vascular disease remains uncertain due to insufficient studies and evidence. This study aims to investigate the causal effects of lipid-lowering drugs (specifically, inhibitors of APOB, CETP, HMGCR, NPC1L1, and PCSK9) on pulmonary vascular diseases using a Mendelian randomization (MR) approach. We utilized summary-level statistics from genome-wide association studies (GWAS) to simulate the exposure to low-density lipoprotein cholesterol (LDL-C) and its outcomes on pulmonary arterial hypertension (PAH), pulmonary embolism (PE), and pulmonary heart disease (PHD).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!